Home1099 • HKG
add
Sinopharm Group Co Ltd
Nakaraang pagsara
$18.37
Sakop ng araw
$18.34 - $18.54
Sakop ng taon
$16.74 - $22.35
Market cap
57.95B HKD
Average na Volume
5.61M
P/E ratio
7.75
Dividend yield
4.01%
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 144.38B | -2.09% |
Gastos sa pagpapatakbo | 6.36B | -6.80% |
Net na kita | 2.00B | -12.11% |
Net profit margin | 1.39 | -9.74% |
Kita sa bawat share | — | — |
EBITDA | 5.65B | -6.41% |
Aktuwal na % ng binabayarang buwis | 27.77% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 47.16B | 8.83% |
Kabuuang asset | 420.17B | -2.19% |
Kabuuang sagutin | 290.70B | -5.36% |
Kabuuang equity | 129.47B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.71 | — |
Return on assets | 2.71% | — |
Return on capital | 5.26% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 2.00B | -12.11% |
Cash mula sa mga operasyon | 164.40M | -97.47% |
Cash mula sa pag-invest | -1.15B | 11.27% |
Cash mula sa financing | 2.70B | 548.42% |
Net change in cash | 1.71B | -62.83% |
Malayang cash flow | -9.01B | — |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
100,251
